T0	Participants 14 60	social disability in autism spectrum disorder:
T1	Participants 74 150	Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials.
T2	Participants 230 255	autism spectrum disorders
T3	Participants 380 459	data from two federally-funded, multi-site, randomized trials with risperidone.
T4	Participants 460 570	Study 1 included 52 subjects assigned to placebo and 49 subjects to risperidone under double-blind conditions.
T5	Participants 571 690	Study 2 included 49 subjects assigned to risperidone only and 75 subjects assigned to risperidone plus parent training.